Company news

Schrodinger, Inc. news in 2026

Schrodinger, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Schrödinger to Present at UBS Global Healthcare Conference

October 28, 2026

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 26, 2026

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4

October 21, 2026

Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry

October 14, 2026

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

September 9, 2026

Schrodinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

August 6, 2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

August 5, 2026

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

July 27, 2026

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

July 22, 2026

Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 25, 2026

Schrödinger Reports First Quarter 2026 Financial Results

May 5, 2026

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

April 21, 2026

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

February 24, 2026

Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

February 12, 2026

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

February 11, 2026

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

January 12, 2026

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

January 8, 2026

Calls in 2026

Decks in 2026